Skip to main navigation Skip to search Skip to main content

An appraisal of the current scenario in vaccine research for COVID-19

  • Wai Chin Chong
  • , Dinesh K. Chellappan
  • , Shakti D. Shukla
  • , Gregory M. Peterson
  • , Rahul P. Patel
  • , Niraj Kumar Jha
  • , Rajaraman D. Eri
  • , Kamal Dua
  • , Murtaza M. Tambuwala
  • , Madhur D. Shastri
  • Monash University
  • International Medical University
  • University of Technology Sydney
  • University of Tasmania
  • Sharda University
  • Ulster University

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

The recent coronavirus disease 2019 (COVID-19) outbreak has drawn global attention, affecting millions, disrupting economies and healthcare modalities. With its high infection rate, COVID-19 has caused a colossal health crisis worldwide. While information on the comprehensive nature of this infectious agent, SARS-CoV-2, still remains obscure, ongoing genomic studies have been successful in identifying its genomic sequence and the presenting antigen. These may serve as promising, potential therapeutic targets in the effective management of COVID-19. In an attempt to establish herd immunity, massive efforts have been directed and driven toward developing vaccines against the SARS-CoV-2 pathogen. This review, in this direction, is aimed at providing the current scenario and future perspectives in the development of vaccines against SARS-CoV-2.

Original languageEnglish
Article number1397
JournalViruses
Volume13
Issue number7
DOIs
StatePublished - Jul 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Immunity
  • SARS-CoV-2
  • Therapeutic targets
  • Vaccines

Fingerprint

Dive into the research topics of 'An appraisal of the current scenario in vaccine research for COVID-19'. Together they form a unique fingerprint.

Cite this